Mycovia Pharmaceuticals

PharmaceuticalsSeries DDurham, USviamet.com

Latest round

Series D

Last raised

Oct 2014

Total raised

$93M

Investors

9

About Mycovia Pharmaceuticals

Mycovia Pharmaceuticals, founded in 2005 and headquartered in Durham, US, specializes in antifungal therapies., leading to its rebranding.Mycovia Pharmaceuticals offers a range of advanced treatments targeting serious fungal infections. Their key product includes a novel antifungal therapy developed to improve treatment outcomes in patients with challenging infections.Mycovia Pharmaceuticals generates revenue through partnerships and service agreements centered around its innovative antifungal therapies. These agreements typically encompass ongoing support and maintenance services, establishing a recurring revenue model that aligns with client needs in the healthcare sector.Mycovia Pharmaceuticals is focused on expanding its product line with upcoming treatments for various fungal infections, with anticipated launches in late 2024.00 mn to support these initiatives.

Who invested in Mycovia Pharmaceuticals

9 investors across 10 rounds

See all investors in Mycovia Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Oct 21, 2014

    Amount

    $60M

    Investors

    Locked

  2. Series B

    Feb 18, 2011

    Amount

    $15M

    Investors

    Locked

  3. Series B

    Jun 23, 2009

    Amount

    $10M

    Investors

    Locked

  4. Series A

    Aug 25, 2008

    Amount

    $3M

    Investors

    Locked

  5. Series A

    Oct 22, 2007

    Amount

    $1M

    Investors

    Locked

  6. Series A

    Aug 3, 2007

    Amount

    $2.2M

    Investors

    Locked

  7. Series A

    Jun 5, 2007

    Amount

    $1M

    Investors

    Locked

  8. Seed

    Sep 15, 2006

    Amount

    $0.3M

    Investors

    Locked

  9. Seed

    Feb 7, 2006

    Amount

    $0.3M

    Investors

    Locked

  10. Seed

    Aug 16, 2005

    Amount

    $0.1M

    Investors

    Locked

Questions about Mycovia Pharmaceuticals

Who invested in Mycovia Pharmaceuticals?

Mycovia Pharmaceuticals has 9 investors on record across 10 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Mycovia Pharmaceuticals raised?

Mycovia Pharmaceuticals has raised 10 venture rounds. Sign up free to see how much each round raised and the total.

When did Mycovia Pharmaceuticals last raise money?

Mycovia Pharmaceuticals's most recent round on record is a Series D, in Oct 2014.

What does Mycovia Pharmaceuticals do?

Mycovia Pharmaceuticals, founded in 2005 and headquartered in Durham, US, specializes in antifungal therapies.

Where is Mycovia Pharmaceuticals headquartered?

Mycovia Pharmaceuticals is headquartered in Durham, US.

Which VCs invest in companies like Mycovia Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Mycovia Pharmaceuticals's stage. Their profiles are linked below.

Raising like Mycovia Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.